- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05831605
Success Rate Comparison of Venipuncture in Children With and Without Near-infrared Light (ALPIVEINE)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This trial aims to evaluate the act of venipuncture with or without the near-infrared light device for any children requiring a venipuncture for a blood sample in neonatal intensive care and neonatology, and in pediatric emergencies.
For any eligible patient, at least one parent will be approached by a member of the medical or paramedical team trained on the protocol to explain the study to him/her and to be able to include the child during the next venous blood sampling. In case the parent agrees on the child's participation, the investigator is in charge of obtaining an informed consent.
During the next venous blood sampling, the nurse responsible for the patient:
- Takes the next consecutively numbered randomization envelope from the room intended for this purpose. This envelope is opaque and contains the randomization group in which the child is assigned (near infrared light or standard technique)
- Takes a study observation book located in the room intended for this purpose.
- Once the nurse is ready to do the venipuncture and before having identified the vein to be punctured, he/she opens the envelope to find out whether or not near infrared light will be used for spotting the vein to be punctured while the person (caregiver or nurse) who will help him during the collection is present.
- Venous blood sampling according to the technique indicated by the randomization (near infrared light or standard technique) for the first attempt at venipuncture.
- If the first venipuncture attempt fails, the nurse can chose to carry out the 2nd or 3rd attempt with or without near infrared light. Only the first 3 attempts progress will be recorded in the observation book.
- When the venous blood drawing is over, whether it is successful or not, the assistant present during the sampling completes the observation book on the sampling part.
- The notebook and the envelope used are stored in the room intended for this purpose.
To avoid device-related bias, the AccuVein® AV 400 (CE 0086 marking) was chosen. This device uses near infrared light to detect superficial veins under the skin and then projects an image of these veins onto the skin surface, exactly above the veins. The device will be held between 10 and 20 cm perpendicular to the skin, because at this distance the projected image corresponds to the actual size of the veins located below the skin. It will be either attached to an articulated arm in order to free the operator's hands to perform the procedure, or held by an assistant above the venipuncture site. The assistant can reorient the device during the procedure. The light from the AccuVein® device should not be aimed at the child's eyes. In neonatal intensive care and neonatology, during any use, the newborn's eyes will be covered during the procedure's implementation.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Nelly BRIAND, PhD
- Phone Number: +33 1 44 38 18 62
- Email: nelly.briand@aphp.fr
Study Contact Backup
- Name: Delphine DUCOURNAU, Nurse
- Phone Number: +33 1.71.73.88.85
- Email: delphine.ducournau@aphp.fr
Study Locations
-
-
-
Paris, France, 75012
- Recruiting
- Hôpital Trousseau
-
Contact:
- Delphine DUCOURNAU, Nurse
- Phone Number: +33 1.71.73.88.85
- Email: delphine.ducournau@aphp.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria
Any child aged at most 44 weeks + 6 days of corrected term hospitalized in neonatal intensive care and neonatology with a medical prescription for a venous blood sample and with visibility and palpability of the vein under 5mm
*OR
- Any child under the age of 18 in the emergency room with a prescription for a blood test and with visibility and palpability of the vein under 5mm
- One parent agreed on their child participation in this study.
- Patient with health insurance
Exclusion Criteria
- Vital emergency which needs a venous route instalment
- Parental refusal
- Parents who do not speak French
- Patient who has already been included in the study
- Blood sample taken by a medical student or a nursing student or childcare nurse student.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control group
Venipuncture without near-infrared light
|
|
Experimental: Experimental group
Venipuncture with near-infrared light
|
with near-infrared light to locate the veins
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of patients with first venipuncture attempt
Time Frame: at day 0
|
Obtention 0.5 ml of blood
|
at day 0
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Successful venepuncture duration
Time Frame: at day 0
|
Duration from application of tourniquet to obtention of 0.5 ml of blood at most after the 3rd venepuncture attempt
|
at day 0
|
Pain evaluation during venipuncture
Time Frame: at day 0
|
Using FLACC or DAN (acute pain of the new-born) scale (score 0 to 10, 10 is most painful) at most after the 3rd venepuncture attempt
|
at day 0
|
Caregivers's opinion
Time Frame: at day 0
|
Opinion of caregivers on the ease of use, effectiveness and their general satisfaction, using a small questionary (very unsatisfied, unsatisfied, satisfied, very satisfied) at most after the 3rd venepuncture attempt
|
at day 0
|
Collaborators and Investigators
Investigators
- Study Director: Ricardo CARBAJAL, MD, PhD, Assistance Publique - Hôpitaux de Paris
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- D20170121
- ID-RCB (Other Identifier: 2023-A01937-38)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Venipuncture
-
Vitestro B.V.RecruitingPhlebotomy | VenipunctureNetherlands
-
Centre Hospitalier Universitaire, AmiensCompletedGeriatric | VenipunctureFrance
-
University of Witten/HerdeckeNot yet recruitingVenipuncture
-
Saglik Bilimleri UniversitesiCompletedPain | Venipuncture
-
Istanbul University - Cerrahpasa (IUC)Completed
-
Carol MorrealeCompletedPain | Anesthetics, Local | VenipunctureUnited States
-
Meyer Children's HospitalCompleted
-
Saglik Bilimleri UniversitesiCompleted
-
Istanbul Saglik Bilimleri UniversityCompletedNursing Caries | Procedural Complication | Venipuncture Site ReactionTurkey
-
IRCCS Burlo GarofoloCompletedProcedural Pain | VenipunctureItaly
Clinical Trials on venipuncture with near-infrared light
-
China Medical University HospitalNot yet recruiting
-
University of MiamiOffice of Naval Research (ONR)Completed
-
Ohio State UniversityCompletedNeoplasms | Bone Diseases | Musculoskeletal Disease | Skull Base Neoplasms | Skull Neoplasms | Bone NeoplasmUnited States
-
University College, LondonMoorfields Eye Hospital NHS Foundation TrustRecruiting
-
Uludag UniversityCompletedKnowledge, Attitudes, Practice | ImageTurkey
-
Samueli Institute for Information BiologyWilliam Beaumont Army Medical CenterTerminated
-
Washington University School of MedicineNational Institute for Biomedical Imaging and Bioengineering (NIBIB)CompletedBreast Cancer | Breast Tumors | Cancer of Breast | Malignant Neoplasm of Breast | Cancer of the BreastUnited States
-
Cerehealth Corp.Colorado Neurological Institute; Tug McGraw FoundationCompletedTBI (Traumatic Brain Injury)
-
Universidad de ValparaisoComisión Nacional de Investigación Científica y TecnológicaUnknownOpen Angle GlaucomaChile
-
Taipei Medical University Shuang Ho HospitalActive, not recruiting